Close Menu

NEW YORK – Roche announced Thursday that its Cobas BKV test received 510(k) clearance from the US Food and Drug Administration for use with stabilized urine samples.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.